Drug
Abcl575
Abcl575: highest development phase Phase 1, developed by AbCellera Biologics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AbCellera Biologics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABCL575 NCT07108894 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Abcl575 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.